Resources
Proteomics Databases
Metabolomics Databases

-
• How to Evaluate De Novo Protein Sequencing Services: Cost, Timeline, and Deliverables
Introduction Once a research team decides that protein-level sequence recovery is necessary, the next challenge is often commercial rather than technical. How much should a de novo protein sequencing project cost? What deliverables justify the expense?
-
• Hybridoma Sequencing: How Antibody Variable Region Recovery Works
Introduction Hybridoma cell lines remain a common source of monoclonal antibodies in discovery, diagnostics, and early development. A hybridoma may produce a useful binder, yet the exact heavy-chain and light-chain variable region sequences may be missing from lab records. Without VH and VL sequence information, teams cannot reliably move to recombinant expression, antibody engineering, sequence documentation, or long-term cell line backup. Hybridoma sequencing is the process of recovering antibody s......
-
• De Novo Sequencing: How LC-MS/MS Determines Protein Sequences Without a Database
Introduction Protein sequence information is often required before a research team can move forward with expression, functional validation, publication, or quality documentation. In many projects, however, no reliable reference sequence exists. The protein may come from an unannotated organism, a proprietary expression system, a legacy purified sample, or a recombinant product that has not yet been fully verified. Standard database-assisted mass spectrometry depends on matching experimental spectra t......
-
• De Novo Sequencing vs Database-Assisted MS: Choosing the Right Protein Sequence Method
Introduction Protein sequence analysis projects rarely begin with a method already chosen. More often, a team starts with a sample and a decision to make: confirm a recombinant product, identify an unknown band, recover an antibody sequence, or document primary structure for publication or QC release. The same LC-MS/MS platform may support multiple workflows, but the best analytical route depends on whether a reliable reference sequence exists. Researchers commonly compare de novo sequencing, databas......
-
• How to Perform De Novo Protein Sequencing: From Protein Preparation to Sequence Reconstruction
Introduction De novo protein sequencing is often requested when a purified protein must be characterized, but no reliable reference sequence is available. A gel band from an expression experiment, a legacy purified fraction, or a recombinant batch with incomplete records can all create the same problem. The protein is present, yet the amino acid sequence remains unknown. Database-assisted identification may return weak matches, partial coverage, or no usable assignment. In these cases, the project nee......
-
• How Much Does De Novo Sequencing Cost? Key Factors to Consider Before Starting
Researchers evaluating de novo sequencing often ask for a single price before the sample details are clear. That question is understandable. Grant budgets, project timelines, and vendor comparisons all depend on cost predictability. However, the service is rarely sold as a one-size- fits-all assay. The price depends on what must be sequenced, how clean the sample is, how much coverage is required, and how much manual interpretation and validation are included in the final report.
-
• De Novo Sequencing vs Database Search: Which Approach Fits Your Study?
The choice is not simply about which method is more advanced. Reference-based search and sequence-from-spectrum analysis answer different questions. Database search asks which known sequence best explains an MS/MS spectrum. De novo sequencing asks what sequence the spectrum itself supports. Selecting the wrong approach can waste instrument time, produce false confidence, or miss the biologically important peptide entirely.
-
• How to Perform De Novo Sequencing: Key Steps for Reliable Peptide Identification
Researchers often need protein sequence evidence when a construct file, transcript, or database entry is incomplete. A purified band may require confirmation before cloning. A recombinant batch may need QC documentation. An antibody product may lack full genetic records. A protein from a non-model organism may have no reliable reference proteome.
-
• De Novo Sequencing: Principles, Advantages, and Applications in Proteomics Research
De novo sequencing addresses this gap by deriving peptide sequence directly from tandem mass spectra. Instead of asking which known protein best explains a spectrum, the method reconstructs the amino acid sequence from fragment ion patterns. This makes the approach valuable when the biological question depends on sequence information that is missing, incomplete, or intentionally modified.
-
• How Much Does Antibody Sequencing Cost? Factors That Influence Project Scope
Researchers evaluating de novo protein sequencing often ask for a single price before the sample details are clear. That question is understandable. Grant budgets, vendor comparisons, and project timelines all depend on cost predictability. However, de novo protein sequencing is rarely a one-size-fits-all service.
How to order?
